FLASH SPRING SALE: 50% Off Premium Subscription >> FLASH SPRING SALE: 50% Off Premium >>
$0.190
+0.0035 (+1.88%)
At Close: May 01, 2024
Forecast Earnings Fundamentals Insider Trading Signals Historical Prices Predictions News Profile

Range Low Price High Price Comment
30 days $0.145 $0.238 Wednesday, 1st May 2024 GRTX stock ended at $0.190. This is 1.88% more than the trading day before Tuesday, 30th Apr 2024. During the day the stock fluctuated 3.37% from a day low at $0.184 to a day high of $0.190.
90 days $0.131 $0.290
52 weeks $0.0853 $3.59

Historical Galera Therapeutics, Inc. prices

Date Open High Low Close Volume
May 01, 2024 $0.186 $0.190 $0.184 $0.190 585 922
Apr 30, 2024 $0.187 $0.197 $0.173 $0.186 389 945
Apr 29, 2024 $0.194 $0.197 $0.180 $0.183 344 865
Apr 26, 2024 $0.201 $0.217 $0.186 $0.186 2 109 375
Apr 25, 2024 $0.180 $0.210 $0.176 $0.208 662 153
Apr 24, 2024 $0.173 $0.190 $0.162 $0.183 814 324
Apr 23, 2024 $0.195 $0.197 $0.188 $0.194 351 985
Apr 22, 2024 $0.181 $0.196 $0.181 $0.191 667 237
Apr 19, 2024 $0.188 $0.194 $0.181 $0.184 800 274
Apr 18, 2024 $0.214 $0.214 $0.172 $0.186 3 762 870
Apr 17, 2024 $0.192 $0.238 $0.180 $0.198 17 656 128
Apr 16, 2024 $0.150 $0.170 $0.145 $0.170 1 022 730
Apr 15, 2024 $0.161 $0.164 $0.152 $0.153 560 727
Apr 12, 2024 $0.160 $0.164 $0.158 $0.159 347 856
Apr 11, 2024 $0.165 $0.165 $0.156 $0.160 239 065
Apr 10, 2024 $0.162 $0.166 $0.160 $0.160 374 285
Apr 09, 2024 $0.160 $0.168 $0.158 $0.163 294 457
Apr 08, 2024 $0.160 $0.170 $0.155 $0.161 575 275
Apr 05, 2024 $0.157 $0.170 $0.156 $0.166 424 847
Apr 04, 2024 $0.152 $0.164 $0.152 $0.162 759 395
Apr 03, 2024 $0.155 $0.158 $0.151 $0.154 849 049
Apr 02, 2024 $0.165 $0.170 $0.148 $0.151 2 170 415
Apr 01, 2024 $0.194 $0.205 $0.153 $0.166 21 254 392
Mar 28, 2024 $0.160 $0.185 $0.131 $0.140 3 247 571
Mar 27, 2024 $0.180 $0.180 $0.151 $0.154 2 348 912
Click to get the best stock tips daily for free!

About Galera Therapeutics, Inc.

Galera Therapeutics. Galera Therapeutics, Inc., a clinical stage biopharmaceutical company, focuses on the development and commercialization of therapeutics for the transformation of radiotherapy in cancer. The company's lead product candidate is avasopasem manganese (GC4419), a small molecule superoxide dismutase mimetic, which has completed Phase III clinical trial for the treatment of radiotherapy induced severe oral mucositis in patients with head and neck cancer... GRTX Profile

Golden Star

Ticker Date Change Price
ETSY Apr 26 1.84% $67.43
DHT Apr 24 1.24% $11.28
LPLA Apr 19 2.49% $262.59
MLI Apr 19 6.77% $52.28
PFLT Apr 18 1.07% $11.25
DOOR Apr 18 0.88% $131.39
LNG Apr 17 0.644% $156.81
FCN Apr 16 2.99% $207.62
ELV Apr 16 4.26% $506.97
ITCI Apr 05 4.92% $68.44
Unlock

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT